Tissue Engineering in Osteoarthritis: Current Status and Prospect of Mesenchymal Stem Cell Therapy Gun-Il Im Leading Article 27 April 2018 Pages: 183 - 192
Efficacy and Safety Outcomes for Originator TNF Inhibitors and Biosimilars in Rheumatoid Arthritis and Psoriasis Trials: A Systematic Literature Review Robert J. MootsCinzia CurialeEduardo Mysler Systematic Review 22 May 2018 Pages: 193 - 199
Therapeutic Targeting of the Interleukin-4/Interleukin-13 Signaling Pathway: In Allergy and Beyond Danielle Karo-AtarAlmog BittonAriel Munitz Review Article 07 May 2018 Pages: 201 - 220
Overcoming Tumor-Induced Immune Suppression: From Relieving Inhibition to Providing Costimulation with T Cell Agonists Dana A. EmersonWilliam L. Redmond Review Article 10 April 2018 Pages: 221 - 231
Anticalin® Proteins as Therapeutic Agents in Human Diseases Christine RotheArne Skerra Review Article Open access 10 May 2018 Pages: 233 - 243
Humanized Mouse Models for the Preclinical Assessment of Cancer Immunotherapy Anja Kathrin Wege Review Article 27 March 2018 Pages: 245 - 266
Knowledge of Adverse Drug Reaction Reporting and the Pharmacovigilance of Biological Medicines: A Survey of Healthcare Professionals in Ireland J. O’CallaghanB. T. GriffinMargaret Bermingham Original Research Article Open access 02 May 2018 Pages: 267 - 280
Determining the Value of Two Biologic Drugs for Chronic Inflammatory Skin Diseases: Results of a Multi-Criteria Decision Analysis Néboa ZozayaLucía Martínez-GaldeanoÁlvaro Hidalgo-Vega Original Research Article Open access 29 May 2018 Pages: 281 - 291
SB3 (Ontruzant®): A Trastuzumab Biosimilar Yvette N. Lamb Adis Biosimilar Brief 23 May 2018 Pages: 293 - 296